TrialPediatric radiology2012

Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromas.

Boaz Karmazyn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.